Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: S-8, Date: 2012-08-17
Original SEC Filing: Click here

---

Webplus: BSPM/20120817/S-8/1/000.htm SEC Original: biostarpharma-s8_080112.htm
FORMS-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China 712046luding zipde) (Full title of the plan) Ronghua Wang President and Chief Executive Officer

---

---

Webplus: BSPM/20120817/S-8/2_EX-4/000.htm SEC Original: ex4-1.htm
Biostar Pharmaceuticals, 2011 Stock Optionmpensation Plan This Biostar Pharmaceuticals, 2011 Stock Optionmpensation Plan Plan 1. Definitions. (a) Board ” (b)de ” (c)mmittee Rule 16b-3 Exchange Act ” (d)mpany ” (e) Exchange Act ” (f) Fair Market Value ” (g) Grant ” (h) Grantreement

---

---

Webplus: BSPM/20120817/S-8/3_EX-5/000.htm SEC Original: ex5-1.htm
[Cozen OConnor Letterhead] August 16, 2012 Biostar Pharmaceuticals, No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China 712046 Re: Registration Statement on Form S-8 Very truly yours, ex5-1.htm 3 EX-5

---

---

Webplus: BSPM/20120817/S-8/4_EX-23/000.htm SEC Original: ex23-2.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to theorporation by reference in the Registration Statement on Form S-8of Biostar Pharmaceuticals, of our reportted March 27, 2012 relating to thensolidation financial statements, which appears in the Annual Report on Form 10-K of Biostar Pharmaceuticals, for the

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: S-8, Date: 2012-08-17CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046